Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating the feasibility and acceptability of an adapted fencing intervention in breast cancer surgery post-operative care: the RIPOSTE pilot randomized trial.
Hasnaoui S, Van Hoye A, Soudant M, Rotonda C, Carvalho de Freitas A, Peiffert D, Delattre C, Raft J, Temperelli M, Allado E, Hily O, Chenuel B, Hornus-Dragne D, Omorou AY, Poussel M. Hasnaoui S, et al. Among authors: peiffert d. Front Oncol. 2024 Apr 11;14:1335442. doi: 10.3389/fonc.2024.1335442. eCollection 2024. Front Oncol. 2024. PMID: 38665959 Free PMC article.
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Masson I, Larriviere L, Mahé MA, Azria D, Pommier P, Mesgouez-Nebout N, Giraud P, Peiffert D, Chauvet B, Dudouet P, Salem N, Noël G, Khalifa J, Latorzeff I, Guérin-Charbonnel C, Supiot S. Masson I, et al. Among authors: peiffert d. Clin Transl Radiat Oncol. 2023 Nov 17;44:100702. doi: 10.1016/j.ctro.2023.100702. eCollection 2024 Jan. Clin Transl Radiat Oncol. 2023. PMID: 38111609 Free PMC article.
A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial.
Pasquier D, Nickers P, Peiffert D, Maingon P, Pommier P, Lacornerie T, Tresch E, Barthoulot M, Lartigau E. Pasquier D, et al. Among authors: peiffert d. Eur Urol Open Sci. 2023 Jul 4;54:80-87. doi: 10.1016/j.euros.2023.06.003. eCollection 2023 Aug. Eur Urol Open Sci. 2023. PMID: 37545850 Free PMC article.
Response to the letter-to-the-editor "In regard to: Dosimetric predictive factors for facial nerve paralysis after Cyberknife stereotactic radiotherapy for vestibular schwannomas: A single institution experience of 88 patients".
Gehin W, Lassalle B, Salleron J, Anxionnat R, Peiffert D, Marchesi V, Bernier-Chastagner V. Gehin W, et al. Among authors: peiffert d. Radiother Oncol. 2023 Oct;187:109797. doi: 10.1016/j.radonc.2023.109797. Epub 2023 Jul 7. Radiother Oncol. 2023. PMID: 37422268 No abstract available.
252 results